ID STX1B_RAT Reviewed; 288 AA. AC P61265; P32853; DT 10-MAY-2004, integrated into UniProtKB/Swiss-Prot. DT 10-MAY-2004, sequence version 1. DT 27-MAR-2024, entry version 147. DE RecName: Full=Syntaxin-1B; DE AltName: Full=P35B; DE AltName: Full=Syntaxin-1B2; GN Name=Stx1b; Synonyms=Stx1b2; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 1-16 AND 31-55. RC TISSUE=Brain; RX PubMed=1321498; DOI=10.1126/science.1321498; RA Bennett M.K., Calakos N., Scheller R.H.; RT "Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at RT presynaptic active zones."; RL Science 257:255-259(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=7690687; DOI=10.1016/0092-8674(93)90466-4; RA Bennett M.K., Garcia-Arraras J.E., Elferink L.A., Peterson K.E., RA Fleming A.M., Hazuka C.D., Scheller R.H.; RT "The syntaxin family of vesicular transport receptors."; RL Cell 74:863-873(1993). RN [3] RP PROTEIN SEQUENCE OF 189-197; 204-209 AND 232-245, AND IDENTIFICATION BY RP MASS SPECTROMETRY. RC STRAIN=Sprague-Dawley; TISSUE=Brain; RA Lubec G., Kang S.U., Lubec S.; RL Submitted (SEP-2007) to UniProtKB. RN [4] RP FUNCTION, AND PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION) BY C.BOTULINUM RP NEUROTOXIN TYPE C. RX PubMed=7901002; DOI=10.1002/j.1460-2075.1993.tb06171.x; RA Blasi J., Chapman E.R., Yamasaki S., Binz T., Niemann H., Jahn R.; RT "Botulinum neurotoxin C1 blocks neurotransmitter release by means of RT cleaving HPC-1/syntaxin."; RL EMBO J. 12:4821-4828(1993). RN [5] RP FUNCTION, AND PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION) BY C.BOTULINUM RP NEUROTOXIN TYPE C. RX PubMed=7737992; DOI=10.1074/jbc.270.18.10566; RA Schiavo G., Shone C.C., Bennett M.K., Scheller R.H., Montecucco C.; RT "Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the RT carboxyl-terminal region of syntaxins."; RL J. Biol. Chem. 270:10566-10570(1995). RN [6] RP PHOSPHORYLATION AT SER-14. RX PubMed=12692561; DOI=10.1038/nbt819; RA Wu C.C., MacCoss M.J., Howell K.E., Yates J.R. III; RT "A method for the comprehensive proteomic analysis of membrane proteins."; RL Nat. Biotechnol. 21:532-538(2003). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). CC -!- FUNCTION: Potentially involved in docking of synaptic vesicles at CC presynaptic active zones (PubMed:7901002). May mediate Ca(2+)- CC regulation of exocytosis acrosomal reaction in sperm (By similarity). CC {ECO:0000250, ECO:0000305|PubMed:7901002}. CC -!- SUBUNIT: Interacts with OTOF. Interacts with SYT6 and SYT8; the CC interaction is Ca(2+)-dependent (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC P61265; Q8CJB9: Rnf40; NbExp=4; IntAct=EBI-2255905, EBI-6110162; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type IV CC membrane protein {ECO:0000305}. CC -!- TISSUE SPECIFICITY: Cerebral cortex, hippocampus, cerebellum, and CC adrenal medulla. CC -!- PTM: Phosphorylated by CK2. {ECO:0000269|PubMed:12692561}. CC -!- PTM: (Microbial infection) Targeted and hydrolyzed by C.botulinum CC neurotoxin type C (BoNT/C), which hydrolyzes the 252-Lys-|-Ala-253 bond CC (PubMed:7737992). Cleavage inhibits neurotransmitter release CC (PubMed:7901002). {ECO:0000269|PubMed:7737992, CC ECO:0000269|PubMed:7901002}. CC -!- SIMILARITY: Belongs to the syntaxin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M95735; AAA42197.1; -; mRNA. DR PIR; B48213; B48213. DR RefSeq; NP_036832.1; NM_012700.2. DR AlphaFoldDB; P61265; -. DR SMR; P61265; -. DR BioGRID; 247029; 5. DR CORUM; P61265; -. DR IntAct; P61265; 3. DR MINT; P61265; -. DR STRING; 10116.ENSRNOP00000026063; -. DR iPTMnet; P61265; -. DR PhosphoSitePlus; P61265; -. DR SwissPalm; P61265; -. DR jPOST; P61265; -. DR PaxDb; 10116-ENSRNOP00000026063; -. DR Ensembl; ENSRNOT00000026063.5; ENSRNOP00000026063.2; ENSRNOG00000019193.5. DR Ensembl; ENSRNOT00055051517; ENSRNOP00055042461; ENSRNOG00055029735. DR Ensembl; ENSRNOT00060041807; ENSRNOP00060034664; ENSRNOG00060024103. DR Ensembl; ENSRNOT00065025135; ENSRNOP00065019675; ENSRNOG00065015178. DR GeneID; 24923; -. DR KEGG; rno:24923; -. DR UCSC; RGD:3784; rat. DR AGR; RGD:3784; -. DR CTD; 112755; -. DR RGD; 3784; Stx1b. DR eggNOG; KOG0810; Eukaryota. DR GeneTree; ENSGT01030000234627; -. DR HOGENOM; CLU_042423_2_2_1; -. DR InParanoid; P61265; -. DR OrthoDB; 2876074at2759; -. DR PhylomeDB; P61265; -. DR TreeFam; TF313763; -. DR Reactome; R-RNO-5682910; LGI-ADAM interactions. DR PRO; PR:P61265; -. DR Proteomes; UP000002494; Chromosome 1. DR Bgee; ENSRNOG00000019193; Expressed in frontal cortex and 15 other cell types or tissues. DR GO; GO:0012505; C:endomembrane system; IBA:GO_Central. DR GO; GO:0016020; C:membrane; ISS:ParkinsonsUK-UCL. DR GO; GO:0031594; C:neuromuscular junction; ISO:RGD. DR GO; GO:0005886; C:plasma membrane; ISS:ParkinsonsUK-UCL. DR GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO. DR GO; GO:0042734; C:presynaptic membrane; IDA:ParkinsonsUK-UCL. DR GO; GO:0031201; C:SNARE complex; IBA:GO_Central. DR GO; GO:0019904; F:protein domain specific binding; IPI:RGD. DR GO; GO:0005102; F:signaling receptor binding; IPI:ParkinsonsUK-UCL. DR GO; GO:0005484; F:SNAP receptor activity; IBA:GO_Central. DR GO; GO:0000149; F:SNARE binding; IBA:GO_Central. DR GO; GO:0098967; P:exocytic insertion of neurotransmitter receptor to postsynaptic membrane; IMP:SynGO. DR GO; GO:0006886; P:intracellular protein transport; IBA:GO_Central. DR GO; GO:1905302; P:negative regulation of macropinocytosis; ISS:ParkinsonsUK-UCL. DR GO; GO:0010977; P:negative regulation of neuron projection development; ISS:ParkinsonsUK-UCL. DR GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISS:ParkinsonsUK-UCL. DR GO; GO:0001956; P:positive regulation of neurotransmitter secretion; ISS:ParkinsonsUK-UCL. DR GO; GO:0072657; P:protein localization to membrane; IDA:ParkinsonsUK-UCL. DR GO; GO:0017157; P:regulation of exocytosis; IMP:RGD. DR GO; GO:0010468; P:regulation of gene expression; ISS:ParkinsonsUK-UCL. DR GO; GO:0060025; P:regulation of synaptic activity; ISS:ParkinsonsUK-UCL. DR GO; GO:0010807; P:regulation of synaptic vesicle priming; ISS:ParkinsonsUK-UCL. DR GO; GO:0016081; P:synaptic vesicle docking; ISS:ParkinsonsUK-UCL. DR GO; GO:0016079; P:synaptic vesicle exocytosis; ISO:RGD. DR GO; GO:0031629; P:synaptic vesicle fusion to presynaptic active zone membrane; ISO:RGD. DR GO; GO:0048278; P:vesicle docking; IBA:GO_Central. DR GO; GO:0006904; P:vesicle docking involved in exocytosis; ISS:ParkinsonsUK-UCL. DR GO; GO:0006906; P:vesicle fusion; IBA:GO_Central. DR GO; GO:0016192; P:vesicle-mediated transport; IMP:RGD. DR CDD; cd15880; SNARE_syntaxin1; 1. DR CDD; cd00179; SynN; 1. DR Gene3D; 1.20.5.110; -; 1. DR Gene3D; 1.20.58.70; -; 1. DR InterPro; IPR010989; SNARE. DR InterPro; IPR045242; Syntaxin. DR InterPro; IPR006012; Syntaxin/epimorphin_CS. DR InterPro; IPR006011; Syntaxin_N. DR InterPro; IPR000727; T_SNARE_dom. DR PANTHER; PTHR19957; SYNTAXIN; 1. DR PANTHER; PTHR19957:SF334; SYNTAXIN-1B; 1. DR Pfam; PF05739; SNARE; 1. DR Pfam; PF00804; Syntaxin; 1. DR SMART; SM00503; SynN; 1. DR SMART; SM00397; t_SNARE; 1. DR SUPFAM; SSF47661; t-snare proteins; 1. DR PROSITE; PS00914; SYNTAXIN; 1. DR PROSITE; PS50192; T_SNARE; 1. DR Genevisible; P61265; RN. PE 1: Evidence at protein level; KW Coiled coil; Direct protein sequencing; Membrane; KW Neurotransmitter transport; Phosphoprotein; Reference proteome; KW Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..288 FT /note="Syntaxin-1B" FT /id="PRO_0000210194" FT TOPO_DOM 1..264 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 265..288 FT /note="Helical; Anchor for type IV membrane protein" FT /evidence="ECO:0000255" FT DOMAIN 191..253 FT /note="t-SNARE coiled-coil homology" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00202" FT REGION 1..20 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COILED 29..104 FT /evidence="ECO:0000255" FT SITE 252..253 FT /note="(Microbial infection) Cleavage; by C.botulinum FT neurotoxin type C (BoNT/C)" FT /evidence="ECO:0000269|PubMed:7737992" FT MOD_RES 10 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P61264" FT MOD_RES 14 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:12692561, FT ECO:0007744|PubMed:22673903" SQ SEQUENCE 288 AA; 33245 MW; 2733497E02978BEB CRC64; MKDRTQELRS AKDSDDEEEV VHVDRDHFMD EFFEQVEEIR GCIEKLSEDV EQVKKQHSAI LAAPNPDEKT KQELEDLTAD IKKTANKVRS KLKAIEQSIE QEEGLNRSSA DLRIRKTQHS TLSRKFVEVM TEYNATQSKY RDRCKDRIQR QLEITGRTTT NEELEDMLES GKLAIFTDDI KMDSQMTKQA LNEIETRHNE IIKLETSIRE LHDMFVDMAM LVESQGEMID RIEYNVEHSV DYVERAVSDT KKAVKYQSKA RRKKIMIIIC CVVLGVVLAS SIGGTLGL //